Patent: 9,765,298
✉ Email this page to a colleague
Summary for Patent: 9,765,298
Title: | Methods and materials for providing cardiac cells |
Abstract: | This document provides methods and materials relating to cardiac cells. For example, this document provides methods and materials that can be used to obtain cells having the ability to differentiate into cardiomyocytes. Such cells can be used to repair damaged heart tissue. For example, cells having the ability to differentiate into cardiomyocytes can be used to repair or regenerate heart tissue in patients with a cardiac condition (e.g., ischemic cardiomyopathy, myocardial infarction, or heart failure). |
Inventor(s): | Terzic; Andre (Rochester, MN), Behfar; Atta (Rochester, MN) |
Assignee: | Mayo Foundation for Medical Education and Research (Rochester, MN) |
Application Number: | 11/674,461 |
Patent Claims: | see list of patent claims |
Details for Patent 9,765,298
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Omrix Biopharmaceuticals Ltd | EVITHROM | thrombin, topical (human) | Solution | 125247 | 08/27/2007 | ⤷ Try a Trial | 2026-07-24 |
Omrix Biopharmaceuticals Ltd | EVITHROM | thrombin, topical (human) | For Injection | 125247 | 09/17/2009 | ⤷ Try a Trial | 2026-07-24 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |